Overview of Dr. Kang
Dr. Josephine Kang is a radiation oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and New York-Presbyterian Hospital. She received her medical degree from New York University Grossman School of Medicine and has been in practice 10 years. She is one of 76 doctors at New York-Presbyterian Hospital and one of 76 doctors at New York-Presbyterian Hospital who specialize in Radiation Oncology. She also speaks multiple languages, including Korean. She has more than 30 publications and over 500 citings.
Office
525 East 68th Street
Stich Radiation Center
New York, NY 10065
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2008 - 2012
Flushing Hospital Medical CenterInternship, Transitional Year, 2007 - 2008
New York University School of MedicineClass of 2007
Certifications & Licensure
NY State Medical License 2012 - 2026
MA State Medical License 2008 - 2013- American Board of Radiology Radiation Oncology
Clinical Trials
- Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer Start of enrollment: 2016 Sep 01
- MRI-guided Stereotactic Body Radiotherapy (SBRT) With Simultaneous Integrated Boost for Prostate Cancer Start of enrollment: 2018 Aug 24
- PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer Start of enrollment: 2020 Jan 27
- Join now to see all
Publications & Presentations
PubMed
- 84 citationsBacterial populations as perfect gases: genomic integrity and diversification tensions in Helicobacter pyloriJosephine Kang, Martin J. Blaser
Nature Reviews. Microbiology. 2006-11-01 - 64 citationsUse, complications, and costs of stereotactic body radiotherapy for localized prostate cancerJoshua A. Halpern, Art Sedrakyan, Wei-Chun Hsu, Jialin Mao, Timothy J. Daskivich
Cancer. 2016-08-15 - 70 citationsStereotactic Body Radiotherapy as Treatment for Organ Confined Low- and Intermediate-Risk Prostate Carcinoma, a 7-Year StudyAlan J. Katz, Josephine Kang
Frontiers in Oncology. 2014-09-02
Press Mentions
- Prostate Cancer SBRT Offers ‘Excellent’ Long-Term Oncologic ControlOctober 30th, 2020
Stereotactic Body Radiation for Prostate CancerJune 9th, 2016
Other Languages
- Korean
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
